Stryker

SYK

Market cap $148B

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent trauma care.

Elevating care with Stryker's next generation device, Synchfix EVT, which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting PORTAGE, Mich., Feb. 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of Synchfix™ EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.

SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 Alpha portfolio.

PORTAGE, Mich., Feb. 9, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the limited market release of Mako RPS (Robotic Power System) for Total Knee, an intuitive handheld robotic system that combines Stryker's proven robotics and power tool legacies and represents Mako's expansion into a new robotics platform.

Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

SYK shares rise after fourth-quarter EPS and sales top estimates, fueled by double-digit organic growth and strong adoption of its Mako platform.

Stryker Corporation (SYK) Q4 2025 Earnings Call Transcript